DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 153 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $115 | -99.9% | 10,769 | 0.0% | 0.00% | – |
| Q3 2022 | $112,000 | -21.1% | 10,769 | -4.6% | 0.00% | – |
| Q2 2022 | $142,000 | -3.4% | 11,283 | -16.8% | 0.00% | – |
| Q1 2022 | $147,000 | -23.0% | 13,560 | 0.0% | 0.00% | – |
| Q4 2021 | $191,000 | -26.5% | 13,560 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $260,000 | +237.7% | 13,560 | -36.9% | 0.00% | – |
| Q3 2019 | $77,000 | -14.4% | 21,500 | -4.4% | 0.00% | – |
| Q2 2019 | $90,000 | -45.1% | 22,500 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $164,000 | +2.5% | 22,500 | +28.6% | 0.00% | 0.0% |
| Q4 2018 | $160,000 | +17.6% | 17,500 | +59.1% | 0.00% | 0.0% |
| Q3 2018 | $136,000 | +27.1% | 11,000 | +57.1% | 0.00% | – |
| Q2 2018 | $107,000 | +46.6% | 7,000 | +89.2% | 0.00% | – |
| Q1 2018 | $73,000 | +284.2% | 3,700 | +270.0% | 0.00% | – |
| Q4 2017 | $19,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |